Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma von Carbone, Michele, Minaai, Michael, Takinishi, Yasutaka, Pagano, Ian, Yang, Haining

Volltext

FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model von Szymiczek, Agata, Pastorino, Sandra, Larson, David, Tanji, Mika, Pellegrini, Laura, Xue, Jiaming, Li, Shuangjing, Giorgi, Carlotta, Pinton, Paolo, Takinishi, Yasutaka, Pass, Harvey I, Furuya, Hideki, Gaudino, Giovanni, Napolitano, Andrea, Carbone, Michele, Yang, Haining

Volltext

O10-5 BAP1 cancer syndrome von Takinishi, Yasutaka, Yoshikawa, Yoshie, Emi, Mitsuru, Yang, Haining, Carbone, Michele

Volltext

A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations von Pastorino, Sandra, Yoshikawa, Yoshie, Pass, Harvey I, Emi, Mitsuru, Nasu, Masaki, Pagano, Ian, Takinishi, Yasutaka, Yamamoto, Ryuji, Minaai, Michael, Hashimoto-Tamaoki, Tomoko, Ohmuraya, Masaki, Goto, Keisuke, Goparaju, Chandra, Sarin, Kavita Y, Tanji, Mika, Bononi, Angela, Napolitano, Andrea, Gaudino, Giovanni, Hesdorffer, Mary, Yang, Haining, Carbone, Michele

Volltext

Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma von Bononi, Angela, Goto, Keisuke, Ak, Guntulu, Yoshikawa, Yoshie, Emi, Mitsuru, Pastorino, Sandra, Carparelli, Lorenzo, Ferro, Angelica, Nasu, Masaki, Kim, Jin-Hee, Suarez, Joelle S., Xu, Ronghui, Tanji, Mika, Takinishi, Yasutaka, Minaai, Michael, Novelli, Flavia, Pagano, Ian, Gaudino, Giovanni, Pass, Harvey I., Groden, Joanna, Grzymski, Joseph J., Metintas, Muzaffer, Akarsu, Muhittin, Morrow, Betsy, Hassan, Raffit, Yang, Haining, Carbone, Michele

Volltext

Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations von Carbone, Michele, Pass, Harvey I., Ak, Guntulu, Alexander, H. Richard, Baas, Paul, Baumann, Francine, Blakely, Andrew M., Bueno, Raphael, Bzura, Aleksandra, Cardillo, Giuseppe, Churpek, Jane E., Dianzani, Irma, De Rienzo, Assunta, Emi, Mitsuru, Emri, Salih, Felley-Bosco, Emanuela, Fennell, Dean A., Flores, Raja M., Grosso, Federica, Hayward, Nicholas K., Hesdorffer, Mary, Hoang, Chuong D., Johansson, Peter A., Kindler, Hedy L., Kittaneh, Muaiad, Krausz, Thomas, Mansfield, Aaron, Metintas, Muzaffer, Minaai, Michael, Mutti, Luciano, Nielsen, Maartje, O’Byrne, Kenneth, Opitz, Isabelle, Pastorino, Sandra, Pentimalli, Francesca, de Perrot, Marc, Pritchard, Antonia, Ripley, Robert Taylor, Robinson, Bruce, Rusch, Valerie, Taioli, Emanuela, Takinishi, Yasutaka, Tanji, Mika, Tsao, Anne S., Tuncer, A. Murat, Walpole, Sebastian, Wolf, Andrea, Yang, Haining, Yoshikawa, Yoshie, Zolondick, Alicia, Schrump, David S., Hassan, Raffit

Volltext

Effect of L-NAME on the Synthesis of Plasma Fibrinogen in Mice von Takinishi, Yasutaka, Okazaki, Masako, Oguchi, Katsuji

Volltext

BAP1 is a novel regulator of HIF-1α von Bononi, Angela, Wang, Qian, Zolondick, Alicia A, Bai, Fang, Steele-Tanji, Mika, Suarez, Joelle S, Pastorino, Sandra, Sipes, Abigail, Signorato, Valentina, Ferro, Angelica, Novelli, Flavia, Kim, Jin-Hee, Minaai, Michael, Takinishi, Yasutaka, Pellegrini, Laura, Napolitano, Andrea, Xu, Ronghui, Farrar, Christine, Goparaju, Chandra, Bassi, Cristian, Negrini, Massimo, Pagano, Ian, Sakamoto, Greg, Gaudino, Giovanni, Pass, Harvey I, Onuchic, José N, Yang, Haining, Carbone, Michele

Volltext

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer von Doi, Toshihiko, Yoshino, Takayuki, Fuse, Nozomu, Boku, Narikazu, Yamazaki, Kentaro, Koizumi, Wasaburo, Shimada, Ken, Takinishi, Yasutaka, Ohtsu, Atsushi

Volltext

Randomized phase II study of cetuximab vs. irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study): Compared with ICECR... von Ishibashi, Keiichiro, Nakamura, Masato, Tsuji, Akihito, Takinishi, Yasutaka, Shindo, Yoshiaki, Aoyama, Toru, Sakamoto, Junichi, Oba, Koji, Mishima, Hideyuki

Volltext

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study) von Nakamura, Masato, Aoyama, Toru, Ishibashi, Keiichiro, Tsuji, Akihito, Takinishi, Yasutaka, Shindo, Yoshiaki, Sakamoto, Junichi, Oba, Koji, Mishima, Hideyuki

Volltext

Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06) von Kimura, Yutaka, Fujii, Masashi, Masuishi, Toshiki, Nishikawa, Kazuhiro, Kunisaki, Chikara, Matsusaka, Satoshi, Segawa, Yoshihiko, Nakamura, Masato, Sasaki, Kinro, Nagao, Narutoshi, Hatachi, Yukimasa, Yuasa, Yasuhiro, Asami, Shinya, Takeuchi, Masahiro, Furukawa, Hiroshi, Nakajima, Toshifusa

Volltext

Medical and surgical care of mesothelioma patients and their relatives carrying germline BAP1 mutations von Carbone, Michele, Pass, Harvey I., Ak, Guntulu, Alexander, H. Richard, Baas, Paul, Baumann, Francine, Blakely, Andrew M., Bueno, Raphael, Bzura, Aleksandra, Cardillo, Giuseppe, Churpek, Jane E., Dianzani, Irma, Rienzo, Assunta De, Emi, Mitsuru, Emri, Salih, Felley-Bosco, Emanuela, Fennell, Dean A., Flores, Raja M, Grosso, Federica, Hayward, Nicholas K, Hesdorffer, Mary, Hoang, Chuong D., Johansson, Peter A., Kindler, Hedy L., Kittaneh, Muaiad, Krausz, Thomas, Mansfield, Aaron, Metintas, Muzaffer, Minaai, Michael, Mutti, Luciano, Nielsen, Maartje, O’Byrne, Kenneth, Opitz, Isabelle, Pastorino, Sandra, Pentimalli, Francesca, de Perrot, Marc, Pritchard, Antonia, Ripley, Robert Taylor, Robinson, Bruce, Rusch, Valerie, Taioli, Emanuela, Takinishi, Yasutaka, Tanji, Mika, Tsao, Anne S., Tuncer, A. Murat, Walpole, Sebastian, Wolf, Andrea, Yang, Haining, Yoshikawa, Yoshie, Zolodnick, Alicia, Schrump, David S., Hassan, Raffit

Volltext

The Meaning of a Combination Use of Bevacizumab in Reintroduction of Oxaliplatin for Metastatic Colorectal Cancer von Nishimura, Ken, Nakayama, Norisuke, Egawa, Tomohisa, Kenmochi, Takeshi, Shimada, Ken, Takinishi, Yasutaka, Kobayashi, Koji, Sasaki, Tohru, Akatsuka, Sotaro, Shirahata, Atsushi

Volltext

Investigation of the tolerability of FOLFIRINOX in patients with unresectable advanced pancreatic cancer: Single-institution experience in Japan von Miyashita, Kouichirou, Sekikawa, Takashi, Shimada, Ken, Yamamoto, Taikan, Kaga, Yasuhiro, Nunoue, Toshikazu, Uto, Yu, Kitahara, Yu, Hisamatsu, Atsushi, Saito, Yusuke, Kobayashi, Kouji, Takinishi, Yasutaka, Kinugasa, Eriko

Volltext

Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06) von Kimura, Yutaka, Fujii, Masashi, Masuishi, Toshiki, Nishikawa, Kazuhiro, Kunisaki, Chikara, Matsusaka, Satoshi, Segawa, Yoshihiko, Nakamura, Masato, Sasaki, Kinro, Nagao, Narutoshi, Hatachi, Yukimasa, Yuasa, Yasuhiro, Asami, Shinya, Takeuchi, Masahiro, Furukawa, Hiroshi, Nakajima, Toshifusa

Volltext

A phase I/II study of cetuximab (cet) in combination with S-1 and oxaliplatin (SOX) in first-line treatment for metastatic colorectal cancer (mCRC) (JACCRO CC-06) von Tsuji, Akihito, Sunakawa, Yu, Denda, Tadamichi, Takinishi, Yasutaka, Kotaka, Masahito, Tanioka, Hiroaki, Shimada, Ken, Kochi, Mitsugu, Watanabe, Takanori, Nakamura, Masato, Ueda, Hiroto, Inukai, Michio, Masuishi, Toshiki, Tani, Satoshi, Negoro, Yuji, Okuno, Tatsuya, Takeuchi, Masahiro, Ichikawa, Wataru, Fujii, Masashi, Nakajima, Toshifusa

Volltext

Reintroduction of oxaliplatin for patients with metastatic colorectal cancer refractory to standard chemotherapy regimens von Sasaki, Tohru, Azuma, Mizutomo, Koizumi, Wasaburo, Egawa, Tomohisa, Nagashima, Atsushi, Kenmochi, Takeshi, Shimada, Ken, Takinishi, Yasutaka, Kobayashi, Kouji, Saito, Yusuke, Akatsuka, Sotaro, Arioka, Hitoshi, Nakayama, Norisuke, Nishimura, Ken, Takagi, Seiichi, Shirahata, Atsushi, Soda, Hitoshi

Volltext

A phase II study of cetuximab (cet) and mFOLFOX6 in metastatic colorectal cancer (mCRC) (JACCRO CC-05) von Yamaguchi, Tatsuro, Tsuji, Akihito, Sunakawa, Yu, Nakamura, Masato, Kochi, Mitsugu, Denda, Tadamichi, Shimada, Ken, Tani, Satoshi, Takagane, Akinori, Kotaka, Masahito, Kuramochi, Hidekazu, Koike, Junichi, Furushima, Kaoru, Yonemura, Yutaka, Negoro, Yuji, Takinishi, Yasutaka, Takeuchi, Masahiro, Ichikawa, Wataru, Fujii, Masashi, Nakajima, Toshifusa

Volltext

A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/l-LV/oxaliplatin (mFOLFOX6) plus bevacizmab in patients with metastatic colorectal cancer: The SO... von Takahari, Daisuke, Yamada, Yasuhide, Matsumoto, Hiroshi, Baba, Hideo, Yoshida, Kazuhiro, Nakamura, Masato, Yoshida, Motoki, Iwamoto, Shigeyoshi, Takinishi, Yasutaka, Sakata, Yuh, Morita, Satoshi, Shimada, Yasuhiro, Komatsu, Yoshito, Sasaki, Yasutsuna, Satoh, Taroh, Takahashi, Keiichi, Mishima, Hideyuki, Muro, Kei, Watanabe, Masahiko, Sugihara, Kenichi

Volltext